Bristol-Myers Squibb
Prehabilitation in NHS Cancer Care Report
Pages
44
Time to read
56 mins
Publication
Language
English
Pages
44
Time to read
56 mins
Publication
Language
English
This report serves as a comprehensive analysis of the adoption of prehabilitation within NHS cancer care, produced through a collaboration between Macmillan Cancer Support and Bristol Myers Squibb. The project aimed to investigate how prehabilitation can enhance patient outcomes by preparing individuals for treatment and improving their overall treatment tolerance. The findings are based on data collected from 11 NHS Trusts, which included patient-level data analysis, staff surveys, and case studies. The report outlines the current state of prehabilitation, identifies barriers to its implementation, and discusses the potential benefits of scaling these services. It emphasizes the importance of a multi-modal approach that includes psychological, nutritional, and exercise support. The report also highlights the potential for prehabilitation to alleviate pressures on NHS resources by improving patient flow and reducing the need for unplanned care, ultimately aiming to address the cancer treatment backlog in the UK.